This page is the NIAMS Coalition 2019 Outreach & Education Meeting Summary.

Scientists can distinguish between highly similar cell types using cutting-edge laboratory procedures. Using such techniques, IRP researchers have identified a particular variety of cell in a specific stage of its life cycle as a primary culprit behind the autoimmune disease known as lupus.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) appointed Gayle Lester, Ph.D., as the director of the Division of Extramural Research. Lester had held the position in an acting role since the reorganization of the Institute's extramural program in April 2018. She assumed the director position March 1, 2020 and will continue to oversee both DER and the Office of Extramural Operations (OEO). "Gayle has provided strong leadership during her time as acting head of DER, and I look forward to watching our extramural efforts continue to prosper," Robert H. Carter, M.D., acting director at NIAMS, said

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) appointed Robert A. Colbert, M.D., Ph.D., as the director of the Institute's Clinical Research Program on February 16, 2020. Colbert, who joined the NIAMS in 2008, had served as deputy clinical director since 2012 and as acting clinical director since June 2018. "What excites me about the NIAMS Clinical Research Program director position is the opportunity we have to make an impact," Colbert explained. "We have a number of research programs that are making new discoveries that reveal how diseases develop and evolve and are translating these discoveries into

Follow this link for the original release of this article:

There’s no doubt that the global COVID-19 pandemic has upended our daily lives in unprecedented ways. This crisis has imposed unique challenges for people from all walks of life. I want to take a moment to acknowledge the strength, adaptability and resolve of the entire NIAMS community as we navigate this unpredictable situation.

December 9-10, 2019 Co-Chairs Robert Carter, M.D. Gayle Lester, Ph.D. Ricardo Cibotti, Ph.D. Amanda Boyce, Ph.D. Introduction The NIH K08 and K23 Mentored Research Career Development Awards provide support for a sustained period of "protected time" (3-5 years) for intensive research career development under the guidance of an experienced mentor, or sponsor, in the biomedical, behavioral, or clinical sciences leading to research independence. Previous discussions have identified the K-to-R01 transition as a critical point in the development of clinician scientists’ independent research careers. Purpose NIAMS held its first K Forum in 2012. Based on the positive feedback received from participants

DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE NATIONAL ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES ADVISORY COUNCIL MINUTES OF THE 100th MEETING February 4th, 2020 8:30 a.m. to 3:00 p.m. February 4th, 2020 Council Webcast I. CALL TO ORDER The 100th meeting of the National Arthritis and Musculoskeletal and Skin Diseases Advisory Council (NAMSAC) was held on February 4, 2020, at the National Institutes of Health (NIH) Campus, Building 35, Conference Rooms 620/630. The meeting was chaired by Dr. Robert H. Carter, Acting Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Attendance Council members present: Ms